This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:
Everybody in the lab sector likes to talk about how much it is consolidated across Europe. This week's infographic assesses that claim: it shows that over half the market is still owned by players with less than €100m revenues and only 15.5% by its top two players.
Indian lab group Metropolis kicked off its IPO yesterday (Wednesday, April 3). It hopes to raise Rs 1,200 crore ($175m). We speak to an India-based market expert about the move.
We interview Claudia Pronk, CEO of Atalmedial, one of the largest Dutch diagnostic lab with a network of more than 100 outpatient clinics and collection locations, about its journey to providing doctors with very detailed, actionable diagnoses and also about the Dutch market.
Synlab has opened its first retail blood collection point (BCP) dedicated solely to wellness and genetic testing, which it claims is the first in Europe.
London-listed Russian healthcare provider MD Medical Group (MDMG) began diversifying last year, as a flattening IVF market saw it looking elsewhere for growth.
LSE-listed Integrated Diagnostics Holdings (IDH) has released its full-year results showing substantial growth in profits, revenue and EBITDA. The lab group, which was brought to IPO by CEO Hend el Sherbini in 2015 and is present in Egypt, Jordan, Sudan and Nigeria, has added an additional 40 branches to its network in the last year, […]
Brazilian diagnostics company DASA has reported losses of R $14.5m ($3.8m) for the last quarter of 2018. We ask the company why, and talk to a market expert about its strategy.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
